Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001231919-25-000342

Director sold 117,050 shares at an average $29.34 ($3,433,992)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. Director 2025-10-20 Sale −70,366 $29.63 $2,084,945 1,432,806 I: show line 1 in the form
RA CAPITAL MANAGEMENT, L.P. Director 2025-10-20 Sale −13,817 $29.63 $409,398 1,287 I: show line 2 in the form
RA CAPITAL MANAGEMENT, L.P. Director 2025-10-20 Sale −6,553 $30.12 $197,376 1,426,253 I: show line 3 in the form
RA CAPITAL MANAGEMENT, L.P. Director 2025-10-20 Sale −1,287 $30.12 $38,764 0 I: show line 4 in the form
RA CAPITAL MANAGEMENT, L.P. Director 2025-10-21 Sale −25,027 $28.11 $703,509 1,401,226 I: show line 5 in the form
Open-market sales · 117,050 sh · avg $29.34 · $3,433,992
Loading xslF345X05/form4-10222025_111059.xml…